These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 777003)
41. Experience of nasal application of inactivated influenza vaccine. Fukumi H Dev Biol Stand; 1976; 33():155-61. PubMed ID: 782963 [TBL] [Abstract][Full Text] [Related]
42. Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer. Halasa N; Englund JA; Nachman S; Weinberg GA; Huber VC; Allison K; Dubovsky F; Yi T; McCullers JA; Flynn PM Vaccine; 2011 May; 29(24):4110-5. PubMed ID: 21496468 [TBL] [Abstract][Full Text] [Related]
43. Preparation and characterization of live recombinant influenza vaccine. Stealey VM; McCahon D; Freestone DS Dev Biol Stand; 1976; 33():191-6. PubMed ID: 955267 [TBL] [Abstract][Full Text] [Related]
44. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection. Masurel N; Laufer J J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638 [TBL] [Abstract][Full Text] [Related]
45. The effect of cigarette smoking on susceptibility to epidemic influenza and on serological responses to live attenuated and killed subunit influenza vaccines. MacKenzie JS; MacKenzie IH; Holt PG J Hyg (Lond); 1976 Dec; 77(3):409-17. PubMed ID: 1069819 [TBL] [Abstract][Full Text] [Related]
46. Criteria in the evaluation of live intranasal influenza virus vaccines. Zygraich N Dev Biol Stand; 1976; 33():141-50. PubMed ID: 782962 [TBL] [Abstract][Full Text] [Related]
47. Safety and efficacy of "Alice" influenza virus vaccine in normal healthy adults. Zaky DA; Douglas RG; Betts RF; Roth FK; Rinehart CJ; Hogan PW J Infect Dis; 1976 Jun; 133(6):669-75. PubMed ID: 946973 [TBL] [Abstract][Full Text] [Related]
48. Clinical and serologic effects of Alice strain live attenuated influenza A (H3N2) virus vaccine in an adult population. Miller LW; Togo Y; Hornick RB Med Microbiol Immunol; 1975 Dec; 162(1):15-21. PubMed ID: 1214706 [TBL] [Abstract][Full Text] [Related]
49. Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a/Fujian/411/2002-like H3N2 antigenic variant strain. Mendelman PM; Rappaport R; Cho I; Block S; Gruber W; August M; Dawson D; Cordova J; Kemble G; Mahmood K; Palladino G; Lee MS; Razmpour A; Stoddard J; Forrest BD Pediatr Infect Dis J; 2004 Nov; 23(11):1053-5. PubMed ID: 15545863 [TBL] [Abstract][Full Text] [Related]
50. An outbreak of an influenza type A variant in a closed population: The effect of homologous and heterologous antibody on infection and illness. Greenberg SB; Couch RB; Kasel JA Am J Epidemiol; 1974 Sep; 100(3):209-15. PubMed ID: 4479059 [No Abstract] [Full Text] [Related]
51. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants. Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710 [TBL] [Abstract][Full Text] [Related]
52. Use of influenza A virus vaccines in seronegative children: live cold-adapted versus inactivated whole virus. Feldman S; Wright PF; Webster RG; Roberson PK; Mahoney J; Thompson J; Doolittle M; Lott L; Johnson P; Christoph RC J Infect Dis; 1985 Dec; 152(6):1212-8. PubMed ID: 3905983 [TBL] [Abstract][Full Text] [Related]
53. Use of single radial immunodiffusion test for serological studies in volunteers inoculated with live attenuated influenza virus. Molyneux ME; Beare AS; Callow K; Schild GC J Hyg (Lond); 1974 Oct; 73(2):287-95. PubMed ID: 4214175 [TBL] [Abstract][Full Text] [Related]
54. Potency of influenza vaccines: mouse protection experiments in correlation to field studies in man. Bachmayer H; Liehl E; Schmidt G Dev Biol Stand; 1975; 28():336-9. PubMed ID: 1126577 [TBL] [Abstract][Full Text] [Related]
55. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. Rudenko LG; Slepushkin AN; Monto AS; Kendal AP; Grigorieva EP; Burtseva EP; Rekstin AR; Beljaev AL; Bragina VE; Cox N J Infect Dis; 1993 Oct; 168(4):881-7. PubMed ID: 8376833 [TBL] [Abstract][Full Text] [Related]
56. [Application of an interferonogen--oral live influenza vaccine A2B for treating influenza]. OstrovskiÄ NN; Vengerov II; Lazukina LN; Koiudenko LG; Alekseeva AK Zh Mikrobiol Epidemiol Immunobiol; 1974 Oct; (10):54-6. PubMed ID: 4616545 [No Abstract] [Full Text] [Related]
57. Comparison of antibody and T-cell responses elicited by licensed inactivated- and live-attenuated influenza vaccines against H3N2 hemagglutinin. Basha S; Hazenfeld S; Brady RC; Subbramanian RA Hum Immunol; 2011 Jun; 72(6):463-9. PubMed ID: 21414368 [TBL] [Abstract][Full Text] [Related]
58. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity. Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA J Hyg (Lond); 1983 Jun; 90(3):361-70. PubMed ID: 6863910 [TBL] [Abstract][Full Text] [Related]
59. [Increase in the effectiveness of anti-influenza immunization by use of a combination of inactivated and live vaccine]. Smorodintsev AA; Orlov VA; Ermolaeva OM; Zhilova GP Vopr Virusol; 1978; (5):602-7. PubMed ID: 735019 [TBL] [Abstract][Full Text] [Related]
60. Inactivated influenza virus vaccines in man: a comparative study of subunit and split vaccines using two methods for assessment of antibody responses. Jennings R; Smith TL; Spencer RC; Mellersh AM; Edey D; Fenton P; Potter CW Vaccine; 1984 Mar; 2(1):75-80. PubMed ID: 6531953 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]